Everett E. Vokes to Isotretinoin
This is a "connection" page, showing publications Everett E. Vokes has written about Isotretinoin.
Connection Strength
0.124
-
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006 Apr 05; 98(7):441-50.
Score: 0.071
-
Searching for a standard. J Clin Oncol. 2002 Jan 15; 20(2):359-61.
Score: 0.053